e-Drug3D 906 |
ESZOPICLONE
|
cas 138729-47-2 |
CLASS NERVOUS SYSTEM |
ROUTE (list) ORAL |
ATC code |
PK parameters Tmax 1 HOUR Solubility VERY SLIGHTLY SOLUBLE IN WATER |
Target TARGET GABA RECEPTOR |
DrugCentral Gamma-aminobutyric acid receptor subunit alpha-2 UNIPROT P47869 GABRA2 Gamma-aminobutyric acid receptor subunit alpha-4 UNIPROT P48169 GABRA4 |
Download SDF file | [(7S)-6-(5-chloropyridin-2-yl)-5-oxo-7H-pyrrolo[3,4-b]pyrazin-7-yl] 4-methylpiperazine-1-carboxylate Formula: Calculated chemical properties: MW 388.82 NB_atoms 27 XLogP 1.57 PSA 79.793 NB_HD 0 NB_HA 9 fsp3 0.35 Lipinski(0=no;1=yes) 1 |
FDA NDA 021476 (pdf not found) INN (ESZOPICLONE) LUNESTA (WAYLIS THERAP) APPROVAL= AP YEAR= 2004 NDA 091124 (pdf not found) INN (ESZOPICLONE) ESZOPICLONE (LUPIN LTD) APPROVAL= AP YEAR= 2011 NDA 091169 (pdf not found) INN (ESZOPICLONE) ESZOPICLONE (TEVA) APPROVAL= AP YEAR= 2011 NDA 091165 (pdf not found) INN (ESZOPICLONE) ESZOPICLONE (CHARTWELL RX) APPROVAL= AP YEAR= 2011 DISCONTINUED NDA 091151 (pdf not found) INN (ESZOPICLONE) ESZOPICLONE (MYLAN PHARMS INC) APPROVAL= AP YEAR= 2013 NDA 091103 (pdf not found) INN (ESZOPICLONE) ESZOPICLONE (SUN PHARM) APPROVAL= AP YEAR= 2013 NDA 091166 (pdf not found) INN (ESZOPICLONE) ESZOPICLONE (GLENMARK PHARMS LTD) APPROVAL= AP YEAR= 2014 NDA 091113 (pdf not found) INN (ESZOPICLONE) ESZOPICLONE (ORBION PHARMS) APPROVAL= AP YEAR= 2014 NDA 091024 (pdf not found) INN (ESZOPICLONE) ESZOPICLONE (DR REDDYS) APPROVAL= AP YEAR= 2014 NDA 091153 (pdf not found) INN (ESZOPICLONE) ESZOPICLONE (HIKMA) APPROVAL= AP YEAR= 2014 DISCONTINUED NDA 202929 (pdf not found) INN (ESZOPICLONE) ESZOPICLONE (MACLEODS PHARMS LTD) APPROVAL= AP YEAR= 2015 NDA 208451 (pdf not found) INN (ESZOPICLONE) ESZOPICLONE (AUROBINDO PHARMA) APPROVAL= AP YEAR= 2016 NDA 203087 (pdf not found) INN (ESZOPICLONE) ESZOPICLONE (AVIV PHARMA) APPROVAL= AP YEAR= 2019 DISCONTINUED NDA 206222 (pdf not found) INN (ESZOPICLONE) ESZOPICLONE (IPCA LABS LTD) APPROVAL= AP YEAR= 2023 DISCONTINUED NDA 205504 (pdf not found) INN (ESZOPICLONE) ESZOPICLONE (HETERO LABS LTD V) APPROVAL= AP YEAR= 2024 |
Other links: |